Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Improved hair loss treatment using special particles and surfactants.

Diane is effective for treating acne, seborrhoea, androgenic alopecia, and mild hirsutism in women.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Taking 5 mg/day finasteride can cause side effects in women with hair loss, but these are usually mild and fade over time, making the treatment beneficial in the long run.

Eflornithine cream makes laser hair removal more effective for treating pseudofolliculitis barbae.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

34% of patients on hepatitis C treatment had reversible skin issues.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Local testosterone treatment improved sexual desire in a female with fragile X syndrome.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

New information shows Valproate may protect the brain and reduce breathing failure risk but can cause liver damage and other side effects, with genetics affecting dosage needs.

Compound 4 is a promising treatment for hair loss with low toxicity.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

Finasteride delivery through skin improved using invasomes and iontophoresis.

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.